Infliximab in refractory spondyloarthropathies: a multicentre 38 week open study
英夫利昔单抗治疗难治性脊柱关节病:一项为期 38 周的多中心开放性研究
期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard.2002.004879
Collantes-Estévez, E; Muñoz-Villanueva, M C; Cañete-Crespillo, J D; Sanmartí-Sala, R; Gratacós-Masmitjá, J; Zarco-Montejo, P; Torre-Alonso, J C; González-Fernández, C